DC Healthcare Holdings Berhad (KLSE:DCHCARE)

Malaysia · Delayed Price · Currency is MYR

0.1000

-0.0100 (-9.09%)

At close: Aug 11, 2026

KLSE:DCHCARE Financials Overview

Financials in millions MYR. Fiscal year is January - December.

Millions MYR. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	90.46	87	55.79	67.7	51.96	25.48
Revenue Growth	40.81%	55.93%	-17.59%	30.28%	103.95%	76.34%
Gross Profit	49.84	48.77	21.25	38.41	29.21	13.93
Operating Income	4.61	3.34	-18.91	6.25	13.45	6.58
Net Income	1.16	0.21	-19.65	2.5	9.56	4.6
Earnings Per Share	0.00	0.00	-0.02	0.00	0.01	0.00
EPS Growth	-	-	-	-76.51%	159.62%	142.09%

Revenue by Segment

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Aesthetic Services	79.6	75.78	46.39	58.06	45.05	21.63
General Medical Services	6.81	7.25	6.84	6.96	5.22	3.85
Skincare Products	4.05	3.97	2.56	2.68	1.69	-
Total	90.46	87	55.79	67.7	51.97	25.48

Cash & Debt

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Investments	24.63	26.05	27.59	35.96	9.24	10.94
Total Debt	41.41	44.41	38.83	23.17	24.13	17.75
Net Cash (Debt)	-16.78	-18.36	-11.24	12.79	-14.9	-6.81
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-0.02	-0.02	-0.01	0.01	-0.02	-0.01

Cash Flow & CapEx

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Cash Flow	16.5	16.49	9.34	3.91	12.05	10.5
Capital Expenditures	-15.62	-15.88	-12.95	-16.31	-7.04	-3.01
Free Cash Flow	0.88	0.61	-3.61	-12.4	5.01	7.49
Free Cash Flow Growth	-44.83%	-	-	-	-33.06%	124.66%

Margins

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Gross Margin	55.09%	56.06%	38.08%	56.73%	56.21%	54.66%
Operating Margin	5.10%	3.84%	-33.90%	9.24%	25.87%	25.82%
Pretax Margin	3.10%	1.89%	-36.60%	7.34%	24.20%	24.35%
Profit Margin	1.29%	0.24%	-35.22%	3.70%	18.39%	18.06%
FCF Margin	0.97%	0.70%	-6.48%	-18.32%	9.65%	29.39%

Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PE Ratio	90.42	556.90	-	161.14	-	-
P/FCF Ratio	113.50	187.28	-	-	-	-
PS Ratio	1.10	1.32	3.13	5.96	-	-